Bioartificial Ultrafiltration Device for Islet Encapsulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Type 1 diabetes treatment through islet transplantation faces challenges such as donor availability, poor engraftment, and immune response activation, leading to short-term insulin independence and graft failure, necessitating improved encapsulation methods to protect islets from the immune system.
Innovation Solution
Development of bioartificial ultrafiltration devices with a planar scaffold that encapsulates cells, featuring a semipermeable ultrafiltration membrane to facilitate the exchange of molecules while immunologically isolating insulin-secreting cells, utilizing channels and membranes with controlled pore sizes to allow nutrient transport while blocking immune components.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If islets are transplanted directly into the portal vein, then the treatment is non-invasive and simple, but the immune system attacks the islets causing graft failure and short-term insulin independence
Solution Approach 1:
The patent applies encapsulation technology using semipermeable membranes (thin films) to create a protective barrier around transplanted islets. The membrane acts as a flexible shell that physically isolates the islets from the host immune system while allowing selective passage of molecules, thereby preventing immune rejection and improving graft survival without complicating the transplantation procedure
Solution Approach 2:
The semipermeable membrane serves as an intermediary barrier between the transplanted islets and the host immune system. This mediator allows essential nutrients and insulin to pass through while blocking immune cells and antibodies, thus protecting the graft while maintaining physiological function
2Reliability
If a semipermeable membrane is used to encapsulate islets, then immune protection is improved, but the complexity of the device increases
Solution Approach 1:
The patent employs porous semipermeable membranes with controlled pore sizes to encapsulate islets. These porous materials provide immune protection by blocking immune cells while allowing passage of smaller molecules like glucose and insulin. The porous structure is achieved through established membrane fabrication techniques, keeping the device relatively simple despite the added protective function
Solution Approach 2:
The patent optimizes the pore size parameter of the semipermeable membrane to achieve the desired balance between immune protection and molecular exchange. By carefully controlling the pore size parameter (typically in the range of 0.1-10 micrometers), the membrane effectively blocks immune cells while allowing nutrients and insulin to pass, providing protection without excessive device complexity
3Reliability
If the membrane pore size is reduced to block immune components, then immune isolation is improved, but the transport efficiency of nutrients and insulin decreases
Solution Approach 1:
The patent carefully optimizes the pore size parameter of the semipermeable membrane to achieve the desired balance between immune protection and molecular exchange. By carefully controlling the pore size parameter (typically in the range of 0.1-10 micrometers), the membrane effectively blocks immune cells while allowing nutrients and insulin to pass, providing protection without excessive device complexity
Solution Approach 2:
The patent employs porous semipermeable membranes with controlled pore sizes to encapsulate islets. These porous materials provide immune protection by blocking immune cells while allowing passage of smaller molecules like glucose and insulin. The porous structure is achieved through established membrane fabrication techniques, keeping the device relatively simple despite the added protective function
4Duration of action of stationary object
If islets are encapsulated to protect from immune system, then long-term viability is improved, but the engraftment efficiency decreases
Solution Approach 1:
The patent applies encapsulation technology using semipermeable membranes (thin films) to create a protective barrier around transplanted islets. The membrane acts as a flexible shell that physically isolates the islets from the host immune system while allowing selective passage of molecules, thereby preventing immune rejection and improving graft survival without complicating the transplantation procedure
Solution Approach 2:
The semipermeable membrane serves as an intermediary barrier between the transplanted islets and the host immune system. This mediator allows essential nutrients and insulin to pass through while blocking immune cells and antibodies, thus protecting the graft while maintaining physiological function
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The bioartificial ultrafiltration devices enhance the viability and functionality of transplanted cells by maintaining immune isolation and efficient glucose-insulin kinetics, demonstrating improved long-term viability and insulin production even under cytokine exposure.
Implementation Method 1
a semipermeable ultrafiltration membrane disposed on a first surface of the scaffold and covering the matrix on the first surface
Implementation Method 2
a bioartificial ultrafiltration device... facilitating exchange of molecules between a plurality of channels and cells adjacent the plurality of channels
Data Source
AI summary
Bioartificial ultrafiltration devices comprising a scaffold comprising a population of cells enclosed in a matrix and disposed adjacent a plurality of channels are provided. The population of cells provides molecules such as therapeutic molecules to a subject in need thereof and is supported by the nutrients filtered in an ultrafiltrate from the blood of the subject. The plurality of channels in the scaffold facilitate the transportation of the ultrafiltrate and exchange of molecules between the ultrafiltrate and the population of cells.